JPRN-C000000342已完成4 期
Japan Antiphospholipid syndrome-Stroke Prevention Study - JASPRES
JASPRES team0 个研究点目标入组 100 人开始时间: 2006年3月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 已完成
- 发起方
- 入组人数
- 100
研究概览
简要总结
discontineued
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •Female patients who are pregnant or plans to be pregnant Patients who cannot have warfarin or antiplatetet drugs Patients who are required to take warfarin Patients with severe hepatic, renal or cardiac failure Other inadequate patients for this clinical trial
研究者
相似试验
Unknown
不适用
Antiphospholipid Antibodies & Osteopontin as Risk Factors for Cerebrovascular Stroke in Young AdultsStroke in Young AdultsNCT03561285Assiut University500
Enrolling By Invitation
不适用
Prevalence and Etiologies of Intracranial Stenosis in Patients With Antiphospholipid SyndromeStenosisIntracranial StenosisAntiphospholipid SyndromeNCT05583305Chinese University of Hong Kong60
招募中
不适用
Advancing Care of Primary Aldosteronism in Japan Studyprimary aldosteronsim:PA essential hypertension:EHTJPRN-UMIN000046631St. Marianna University School of Medicine5,000
进行中（未招募）
4 期
Comparison of Clopidogrel-based Antiplatelet Therapy Versus Warfarin as Secondary Prevention Strategy for AntiPhospholipid Syndrome-related STROKEIschemic StrokeCardiovascular DiseasesMajor BleedTransient Ischemic AttackAntiphospholipid SyndromeCerebrovascular DiseaseNCT05995600Seoul National University Hospital200
已完成
4 期
Japanese Primary Prevention of Atherosclerosis With Aspirin for Diabetes (JPAD) TrialCoronary DiseaseArteriosclerosisDiabetes Mellitus, Type 2NCT00110448Kumamoto University2,539